EquityZen Growth Technology Fund LLC - Series 538
Raised
$175K
Investors
15
Min Invest
$10,000
AltStreet Analysis
·Generated from EDGAR primary sources
EquityZen Growth Technology Fund LLC - Series 538 is a Delaware pooled investment fund filed by EquityZen Advisors LLC that raised $175K from 15 investors under Rule 506(b) and Section 3(c)(1) exemptions. The minimum investment was $10K. This is part of EquityZen's platform of nearly 1,900 pre-IPO investment vehicles providing access to private growth-stage technology companies.
This pre-IPO fund utilizes the standard 506(b)/3(c)(1) exemption structure typical of small private investment pools targeting accredited investors. The $10K minimum investment is at the lower end of the spectrum for private funds, consistent with EquityZen's retail-accessible model, while the modest $175K raise and 15-investor count reflect a single-deal SPV structure focused on a specific private company position.
Data Flags
EDGAR Filing Data
Form D — Primary Source
View on SEC.govRelated Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
EquityZen Advisors LLC
Executive Officer, Director · New York, NY
Richard Thoms
Executive Officer · Salt Lake City, UT
Assure Fund Management II LLC
Director · Salt Lake City, UT
Philip Haslett
Executive Officer, Director · New York, NY
Is this your offering?
Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.
